Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmacological Research|August 10, 2020
Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signalingShuo Zhang, Hao Gong, Yunjun Ge, et al.
Journal of Fungi (Basel, Switzerland)|February 26, 2026
Mining Genetically Encoded Biosensors from Filamentous FungiShuhui Guo, Shaozheng Song, Zhunzhun Liu, et al.
Bioscience Reports|October 22, 2014
The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expressionYunjun Ge, Dehua Yang, Antao Dai, et al.
Medicine|June 21, 2024
Systematic analysis of fatty acid desaturases in breast invasive carcinoma: The prognosis, gene mutation, and tumor immune microenvironmentJie Wang, Qian Zhang, Duanrui Zhou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2020
Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activityYunjun Ge, Shuo Zhang, Junlin Wang, et al.
Biochemical Pharmacology|March 6, 2026
Nebivolol-induced bi-directional modulation of intracellular kinases contributes to the inhibition of triple-negative breast cancerHuiwen Guan, Yunjun Ge, Qianqian Cao, et al.
Acta Pharmaceutica Sinica. B|July 23, 2025
Discovery of Yersinia LcrV as a novel biased agonist of formyl peptide receptor 1 to bi-directionally modulate intracellular kinases in triple-negative breast cancerYunjun Ge, Huiwen Guan, Ting Li, et al.
Frontiers in Pharmacology|April 9, 2020
A Ganoderma-Derived Compound Exerts Inhibitory Effect Through Formyl Peptide Receptor 2Huirong Wang, Xingrong Peng, Yunjun Ge, et al.
Scientific Reports|May 20, 2026
SPP1 knockdown inhibits invasion, migration and paclitaxel-induced Epithelial-Mesenchymal Transition in Cervical Cancer Cells through the TGF-β/Akt/Snail pathwayQianqian Cao, Yayin Lin, Huiwen Guan, et al.
Chinese Medicine|December 26, 2024
Lipid droplet formation induced by icaritin derivative IC2 promotes a combination strategy for cancer therapyGuosheng Wu, Liang Ying, Qian Zhang, et al.
Pageof 2